Terms: = Leukemia AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3 AND Clinical Outcome
1 results:
1. Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.
Guru SA; Sumi MP; Mir R; Beg MMA; Koner BC; Saxena A
BMC Cancer; 2022 Apr; 22(1):405. PubMed ID: 35421941
[TBL] [Abstract] [Full Text] [Related]
